The caspase-1 inhibitor VX-765 has shown anti-tumor effects through the inhibition of pyroptosis and reduction in IL-1β secretion in non-small cell lung cancer (NSCLC) models [192]. The gene discussed is CASP1; the disease is neoplasm.